Table 3 Comparisons of differentially expressed phosphorylated peptides related to metabolic pathways treated with PZH and sorafenib from TMT phosphoproteomics and PRM verification.

From: Pien Tze Huang regulates phosphorylation of metabolic enzymes in mice of hepatocellular carcinoma

Uniprot

KEGG pathways

Protein description

Peptide name

Phosphorylation fold change

PZH versus control

Sora versus control

PZH versus sora

TMT

Phospho proteomics

PRM

TMT

Phospho proteomics

PRM

TMT

Phospho proteomics

PRM

O70250

Glucagon signaling pathway

Glycolysis/gluconeogenesis

Phosphoglycerate mutase 2 (PGAM2)

\

\

\

\

\

\

Peptide (residues 129–139):

HGESLWNQENR

0.68#

0.63**

0.88*

0.79*

0.64**

0.80#

Peptide (residues 12–20):

HNYYTSISK

0.48*

0.41**

1.21

0.64**

0.55**

0.63*

P06151

L-lactate dehydrogenase A chain (LDHA)

\

\

\

\

\

\

Peptide (residues 233–243):

QVVDSAYEVIK

0.66

0.45**

1.23

0.72*

0.53**

0.62**

P47857

Glycolysis/gluconeogenesis

HIF-1 signaling pathway

Fructose and mannose metabolism

ATP dependent 6-phosphofructokinase (PFK1)

\

\

\

\

\

\

Peptide (residues 657–673):

NVLGHMQQGGSPTPFDR

0.89

0.25**

1.12

0.23**

0.79*

1.09

P05064

Fructose bisphosphate aldolase A (ALDOA)

\

\

\

\

\

\

Peptide (residues 44–56):

LQSIGTENTEENR

0.84

0.34**

1.18*

0.54*

0.71**

0.53*

Peptide (residues 29–42):

GILAADESTGSIAK

0.57

0.49**

1.50*

0.64**

0.45**

0.76*

Q9QXG4

Glycolysis/gluconeogenesis

Pyruvate, propanoate metabolism

Acetyl-coenzyme A synthetase (ACSS2)

\

\

\

\

\

\

Peptide (residues 28–36):

GWSPPPEVR

0.89

1.08

1.32**

1.26*

0.54*

0.86

P41216

PPAR signaling pathway

Fatty acid biosynthesis/degradation

Long chain fatty acid CoA ligase (ACSL1)

\

\

\

\

\

\

Peptide (residues 421–428):

IQSSLGGK

0.71#

0.25**

1.34*

0.68

0.53**

0.37**

  1. One-way ANOVA, *p < 0.05 versus control group, **p < 0.01 versus control group. The value greater than 1 indicates up-regulation, less than 1 indicates down-regulation.